IK
Ikena Onc
IKNA·NASDAQBoston MAFounded 201650 employees
Micro CapbiotechPublicOncology
Platform: IK-595 MAPK
Market Cap
$0.15B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (IKNA)
Loading IKNA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zorisotorasib | IKN-3106 | Approved | 2 | JAK2 | HSHNSCC | ||
| Polatinib | IKN-8323 | Preclinical | 2 | PLK4 | MGPsoriasis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)